glp-1 and gallstones Suspected drug-induced pancreatitis was rare but more common in patients taking agonists than sulfonylureas, a recent analysis of a VA database finds Gallbladder Risks with GLP-1 Weight

Surveillance Research Program (2021)

Controlling the role of BPC 157 likely involves its particular interaction with the major systems involved in wound healing, such as the NO-system (counteracted harmful events, arising from either NO-blockade or NOS-substrate application) (Sikiric et al., 2014) and the prostaglandins system (i.e., large extent of the counteracted NSAIDs toxicity (Sikiric et al., 2013) as well as counteracted developing and already formed adjuvant arthritis in rats (Sikiric et al., 1997c))

Hot take: GLP-1 spend doesnt have to break the budget So what are large employers missing

doi: 10.7554/eLife.78906 26 WilliamsMJ

Initial selection and transition of therapy should be approached individually and systematically, with prioritization of patients with other comorbidities such as coronary artery disease, chronic kidney disease, and other diabetes complications